Oncolytics Biotech
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -5,612 | -6,902 | -8,339 | -9,794 |
EBIT | -5,706 | -6,999 | -8,437 | -9,899 |
Net Income | -6,165 | -6,687 | -8,017 | -9,543 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,471 | -6,498 | -7,852 | -4,864 |
Cash | 14,626 | 15,303 | 15,942 | 19,598 |
Basic Shares | 90,999 | 84,631 | 76,090 | 77,016 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -403 | -392 | -452 | |
EBITDA | -34,880 | -33,710 | -26,831 | -25,664 |
EBIT | -34,982 | -33,791 | -27,223 | -26,116 |
Net Income | -31,710 | -27,752 | -24,835 | -26,304 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -27,205 | -28,456 | -23,410 | -22,719 |
Cash | 15,942 | 34,912 | 11,666 | 41,262 |
Basic Shares | 76,483 | 67,624 | 58,029 | 53,513 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.07 |
2025-03-31 | -$0.08 |
2024-12-31 | -$0.10 |
